GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sai Parenterals Ltd

Sai Parenterals Board Meeting Scheduled for Q2 FY27 Results Approval

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 27 Oct 2026, 10:44 AM IST  ·  BSE ID: 96b88496-69e6-4378-86e3-1855684e26ed
View Original BSE Filing (PDF)
💡
In Simple Terms
Sai Parenterals will hold a board meeting on November 1, 2026, to approve its financial results for the quarter and half year ended September 30, 2026.
🤖 AI Summary
  • Sai Parenterals Board of Directors meeting scheduled for Sunday, November 1, 2026.
  • Purpose includes considering and approving unaudited financial results for Q2 FY27 and H1 FY27.
  • Both standalone and consolidated financial results for quarter/half year ended September 30, 2026 will be reviewed.
  • A Limited Review Report for the specified periods will also be considered during the meeting.
  • Trading window for designated persons remains closed until 48 hours post results announcement.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this board meeting intimation.
👤
Who Is Affected
Shareholders are indirectly affected as the upcoming financial results will provide updated information on the company's performance for the quarter and half year ended September 30, 2026.
🔍
Management Signal
The scheduling of the board meeting indicates management's adherence to regulatory timelines for financial reporting and transparency.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome for Q2 FY27 and H1 FY27 results on November 1, 2026.
Release of unaudited financial results (standalone and consolidated) for Q2 FY27 and H1 FY27.
Disclosure of the Limited Review Report for the periods ended September 30, 2026.
LOW RISK This filing is a routine announcement of a board meeting for results approval, carrying minimal inherent risk.
💡 Investor Takeaway
Sai Parenterals has scheduled a Board Meeting for November 1, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. This is a procedural announcement ahead of results disclosure.
📅 Company Track Record
Sai Parenterals Ltd was recently listed, with an IPO within the last 12 months. Limited public track record is available. Past filings include an intimation for Q1 FY27 results approval on August 11, 2026, and a request for a 23-day extension to file Q3 FY26 results in April 2026 due to delays related to an acquired Australian subsidiary's audit.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Sai Parenterals Limited's next Board Meeting scheduled?
The Board Meeting of Sai Parenterals Limited is scheduled for Sunday, November 01, 2026.
What will be discussed at the Sai Parenterals Board Meeting on November 01, 2026?
The Board will consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half year ended September 30, 2026.
Is the trading window for Sai Parenterals Limited currently closed?
Yes, the trading window for Sai Parenterals Limited remains closed for Designated Persons and their Immediate Relatives until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.